OC
AMAG

Oppenheimer & Co’s AMAG Pharmaceuticals AMAG Stock Holding History

Oppenheimer & Co’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-30,425
Closed -$1.21M – 1403
2015
Q3 		$1.21M Buy
+30,425
New +$1.89M 0.04% 512
2014
Q4 		– Sell
-7,616
Closed -$243K – 1510
2014
Q3 		$243K Buy
+7,616
New +$162K 0.01% 1159

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Oppenheimer & Co's AMAG Position: Q4 2015 in Review

Oppenheimer & Co sold out of AMAG Pharmaceuticals (AMAG) in Q4 2015, closing a stake of 30,425 shares — an estimated $1.21M sold.

Oppenheimer & Co first reported a position in AMAG in Q3 2014 and held it in 2 quarters. The position peaked at $1.21M in Q3 2015. 172 funds tracked by Wall St. Rank hold AMAG as of Q4 2015.

  • Oppenheimer & Co reported no remaining AMAG Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 30,425 AMAG Pharmaceuticals shares in Q4 2015, an estimated $1.21M.
  • Oppenheimer & Co first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Oppenheimer & Co's AMAG Pharmaceuticals position peaked at $1.21M in Q3 2015.
  • 172 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.